Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Chem Biol. 2012 Jul 27;19(7):875-82. doi: 10.1016/j.chembiol.2012.05.013.

    Identification of exosite-targeting inhibitors of anthrax lethal factor by high-throughput screening.

    Source

    Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520 USA.

    Abstract

    Protease inhibitor discovery has focused almost exclusively on compounds that bind to the active site. Inhibitors targeting protease exosites, regions outside of the active site that influence catalysis, offer potential advantages of increased specificity but are difficult to systematically discover. Here, we describe an assay suitable for detecting exosite-targeting inhibitors of the metalloproteinase anthrax lethal factor (LF) based on cleavage of a full-length mitogen-activated protein kinase kinase (MKK) substrate. We used this assay to screen a small-molecule library and then subjected hits to a secondary screen to exclude compounds that efficiently blocked cleavage of a peptide substrate. We identified a compound that preferentially inhibited cleavage of MKKs compared with peptide substrates and could suppress LF-induced macrophage cytolysis. This approach should be generally applicable to the discovery of exosite-targeting inhibitors of many additional proteases.

    Copyright © 2012 Elsevier Ltd. All rights reserved.

    PMID:
    22840775
    [PubMed - in process]
    PMCID:
    PMC3408624
    [Available on 2013/7/27]

    LinkOut - more resources

    Full Text Sources

    Chemical Information

      Supplemental Content

      Icon for Elsevier Science

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk